BSECompany Update4 Aug 2026 · 4 Aug 2026, 05:11 pm

Emkay Confluence 2026

Krishna Institute of Medical Sciences Ltd · 543308

✦ AI Summary

Krishna Institute of Medical Sciences Ltd has announced an analyst/institutional investor meeting, Emkay Confluence 2026, scheduled for August 12, 2026, in Mumbai, India. The meeting is subject to change due to exigencies, and no unpublished price-sensitive information will be shared.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

821f7aae-26a2-4944-9b4a-de1ecebdc076.pdf

pdf

Download →
View document text
04th August, 2026 To, To, The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange (NSE) Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Plot No.C/1, 'G' Block Mumbai - 400 001. Bandra - Kurla Complex Scrip Code - 543308 Mumbai - 400 051. ISIN: INE967H01025 Symbol - KIMS ISIN: INE967H01025 Dear Sir/Madam, Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Intimation of Schedule of Analyst/ Institutional Investor Meeting. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the details of the proposed schedule of the Analyst/ Institutional Investor Meeting is as follows: Date of Event Venue Type of Meeting Meeting August 12, Emkay Confluence 2026 Mumbai, Group Meeting 2026 India The above schedule is subject to change due to exigencies, if any. No Unpublished Price Sensitive Information will be shared during the meeting. This is for your information and records. Thanking you, Yours truly For Krishna Institute of Medical Sciences Limited Nagajayanthi J.R Company Secretary & Compliance Officer